Menu Search
Equities

Hydrix Ltd

STJ:FRA

Hydrix Ltd

Actions
  • Price (EUR)0.001
  • Today's Change-0.009 / -90.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hydrix Limited is an Australia-based specialist product designing, engineering and medical device distribution company. The Company is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.

  • Revenue in AUD (TTM)12.01m
  • Net income in AUD-2.23m
  • Incorporated1993
  • Employees70.00
  • Location
    Hydrix Ltd30-32 Compark CircuitMULGRAVE 3170AustraliaAUS
  • Phone+61 39550-8100
  • Fax+61 39662-1472
  • Websitehttps://www.hydrix.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.